Medivolve (Medivolve) Inventories, Finished Goods : $0.03 Mil (As of Dec. 2023)

View and export this data going back to 2009. Start your Free Trial

What is Medivolve Inventories, Finished Goods?

Medivolve's quarterly finished goods stayed the same from Jun. 2023 ($0.00 Mil) to Sep. 2023 ($0.00 Mil) but then increased from Sep. 2023 ($0.00 Mil) to Dec. 2023 ($0.03 Mil).

Medivolve's annual finished goods increased from Dec. 2021 ($0.00 Mil) to Dec. 2022 ($0.25 Mil) but then declined from Dec. 2022 ($0.25 Mil) to Dec. 2023 ($0.03 Mil).

Medivolve Inventories, Finished Goods Historical Data

The historical data trend for Medivolve's Inventories, Finished Goods can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medivolve Inventories, Finished Goods Chart

Medivolve Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Inventories, Finished Goods

Get a 7-Day Free Trial

0.25

0.03

Medivolve Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Inventories, Finished Goods	Get a 7-Day Free Trial															0.25	-	-	-	0.03

Medivolve Inventories, Finished Goods Calculation

The products in a manufacturer's inventory that are completed and are waiting to be sold.

Medivolve (Medivolve) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Medivolve Inc (OTCPK:MEDVF) » Definitions » Inventories, Finished Goods

Comparable Companies

Traded in Other Exchanges

4NCA:Germany MEDV:Canada

Address

198 Davenport Road, Toronto, ON, CAN, M5R 1J2

Website

https://www.medivolve.ca

Medivolve Inc is a healthcare technology and services company. It is engaged in finding and developing disruptive technologies, groundbreaking innovations, and partnerships to help combat COVID-19 and transform human health management. The company operated one reportable segment, the COVID Testing facilities across the United States Of America.